iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Associated Banc Corp

Associated Banc Corp cut its position in iShares Biotechnology ETF (NASDAQ:IBB) by 4.8% during the fourth quarter, HoldingsChannel.com reports. The fund owned 42,803 shares of the financial services provider’s stock after selling 2,173 shares during the period. Associated Banc Corp’s holdings in iShares Biotechnology ETF were worth $5,659,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Cullen Frost Bankers Inc. boosted its stake in shares of iShares Biotechnology ETF by 1.5% in the fourth quarter. Cullen Frost Bankers Inc. now owns 5,654 shares of the financial services provider’s stock worth $748,000 after acquiring an additional 82 shares during the last quarter. Transcend Capital Advisors LLC lifted its position in iShares Biotechnology ETF by 0.8% during the fourth quarter. Transcend Capital Advisors LLC now owns 10,958 shares of the financial services provider’s stock worth $1,449,000 after buying an additional 92 shares in the last quarter. Chicago Partners Investment Group LLC lifted its position in iShares Biotechnology ETF by 2.5% during the fourth quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock worth $510,000 after buying an additional 94 shares in the last quarter. WealthCare Investment Partners LLC lifted its position in iShares Biotechnology ETF by 0.9% during the fourth quarter. WealthCare Investment Partners LLC now owns 10,348 shares of the financial services provider’s stock worth $1,375,000 after buying an additional 96 shares in the last quarter. Finally, Capital Investment Advisors LLC lifted its position in iShares Biotechnology ETF by 1.0% during the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after buying an additional 99 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $134.19 on Friday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The company has a market cap of $6.34 billion, a price-to-earnings ratio of 24.52 and a beta of 0.84. The business’s 50 day moving average price is $136.25 and its 200 day moving average price is $139.96.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.